Bone metastases detection by circulating biomarkers: OPG and RANK-L.
about
RANK, RANKL and OPG Expression in Breast Cancer - Influence on Osseous Metastasis.Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid.Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro.RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.Role of RANKL/RANK in primary and secondary breast cancer.
P2860
Bone metastases detection by circulating biomarkers: OPG and RANK-L.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Bone metastases detection by circulating biomarkers: OPG and RANK-L.
@en
Bone metastases detection by circulating biomarkers: OPG and RANK-L.
@nl
type
label
Bone metastases detection by circulating biomarkers: OPG and RANK-L.
@en
Bone metastases detection by circulating biomarkers: OPG and RANK-L.
@nl
prefLabel
Bone metastases detection by circulating biomarkers: OPG and RANK-L.
@en
Bone metastases detection by circulating biomarkers: OPG and RANK-L.
@nl
P2093
P356
P1476
Bone metastases detection by circulating biomarkers: OPG and RANK-L.
@en
P2093
Dino Amadori
Emanuela Flamini
Emanuela Scarpi
Emanuele Sacanna
Laura Mercatali
Marianna Ricci
Patrizia Serra
Rossana Ricci
Toni Ibrahim
Wainer Zoli
P304
P356
10.3892/IJO.2011.1001
P577
2011-04-13T00:00:00Z